Literature DB >> 24674595

Investigation into in vitro and in vivo models using intestinal epithelial IPEC-J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli.

M Zhou1, J Zhu, H Yu, X Yin, P M Sabour, L Zhao, W Chen, J Gong.   

Abstract

AIMS: To identify a fast, economic and reliable method for preselecting lactic acid-producing bacterial (LAB) isolates to control enterotoxigenic Escherichia coli (ETEC). METHODS AND
RESULTS: Two assays with porcine intestinal epithelial IPEC-J2 cells or Caenorhabditis elegans for selecting effective probiotic candidates were compared. Both assays were based on measuring death of cells or worms caused by ETEC strain JG280. Six of 13 LAB isolates showed ≥50% protection in each assay, among which only four isolates (≥50% protection) were consistently selected by both assays. Isolate CL9 (Lactobacillus reuteri) was further studied. It reduced gene expression of estA, estB and elt in JG280 in both assays. Furthermore, the isolate protected IPEC-J2 and C. elegans from cell and worm death caused by STa, STb or LT enterotoxin expressed in E. coli DH5α. CL9 also promoted host defensive responses by decreasing IL-8 and increasing IL-10 production in IPEC-J2 cells and expression of antimicrobial peptide genes clec-60, clec-85 in C. elegans.
CONCLUSIONS: Caenorhabditis elegans is useful for preselecting probiotic candidates to control ETEC after initial screening with IPEC-J2 cells. SIGNIFICANCE AND IMPACT OF THE STUDY: A combination of IPEC-J2 cell and C. elegans assays can improve the effectiveness in preselecting probiotic candidates.
© 2014 Society for Applied Microbiology and Her Majesty the Queen in Right of Canada Reproduced with the permission of the Minister of Agriculture and Agri-Food Canada.

Entities:  

Keywords:  Caenorhabditis elegans; Escherichia coli; IPEC-J2; lactic acid-producing bacteria; models for selection

Mesh:

Substances:

Year:  2014        PMID: 24674595     DOI: 10.1111/jam.12505

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  13 in total

1.  Modeling Host-Microbiome Interactions in Caenorhabditis elegans.

Authors:  Teklu K Gerbaba; Luke Green-Harrison; Andre G Buret
Journal:  J Nematol       Date:  2017-12       Impact factor: 1.402

2.  Dairy Propionibacterium extends the mean lifespan of Caenorhabditis elegans via activation of the innate immune system.

Authors:  Gayeung Kwon; Jiyun Lee; Young-Hee Lim
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

3.  Molecules produced by probiotics prevent enteric colibacillosis in pigs.

Authors:  Ricardo Nordeste; Akalate Tessema; Sapana Sharma; Zlatko Kovač; Chuan Wang; Rocio Morales; Mansel William Griffiths
Journal:  BMC Vet Res       Date:  2017-11-15       Impact factor: 2.741

4.  Probiotics alter biofilm formation and the transcription of Porphyromonas gingivalis virulence-associated genes.

Authors:  Karin Hitomi Ishikawa; Daniela Mita; Dione Kawamoto; Jacques Robert Nicoli; Emmanuel Albuquerque-Souza; Maria Regina Lorenzetti Simionato; Marcia Pinto Alves Mayer
Journal:  J Oral Microbiol       Date:  2020-08-20       Impact factor: 5.474

5.  The TGF-β ligand DBL-1 is a key player in a multifaceted probiotic protection against MRSA in C. elegans.

Authors:  Maria G M Mørch; Katrine V Møller; Marianne O Hesselager; Rikke H Harders; Caroline L Kidmose; Therese Buhl; Kurt Fuursted; Emøke Bendixen; Chong Shen; Lotte G Christensen; Charlotte H Poulsen; Anders Olsen
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

6.  Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models.

Authors:  Charlène Roussel; Kim De Paepe; Wessam Galia; Jana de Bodt; Sandrine Chalancon; Sylvain Denis; Françoise Leriche; Pascal Vandekerkove; Nathalie Ballet; Stéphanie Blanquet-Diot; Tom Van de Wiele
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 7.  Current Perspectives on Gastrointestinal Models to Assess Probiotic-Pathogen Interactions.

Authors:  Mehreen Anjum; Arja Laitila; Arthur C Ouwehand; Sofia D Forssten
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

8.  Lactic acid bacteria that activate immune gene expression in Caenorhabditis elegans can antagonise Campylobacter jejuni infection in nematodes, chickens and mice.

Authors:  Xing Jin; Yufeng He; Yonghua Zhou; Xiaohua Chen; Yuan-Kun Lee; Jianxin Zhao; Hao Zhang; Wei Chen; Gang Wang
Journal:  BMC Microbiol       Date:  2021-06-05       Impact factor: 3.605

Review 9.  Caenorhabditis Elegans and Probiotics Interactions from a Prolongevity Perspective.

Authors:  Marianna Roselli; Emily Schifano; Barbara Guantario; Paola Zinno; Daniela Uccelletti; Chiara Devirgiliis
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

10.  Pediococcus acidilactici P25 Protected Caenorhabditis elegans against Enterotoxigenic Escherichia coli K88 Infection and Transcriptomic Analysis of Its Potential Mechanisms.

Authors:  Keqin Tan; Dun Deng; Xianyong Ma; Yiyan Cui; Zhimei Tian
Journal:  Biomed Res Int       Date:  2020-03-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.